findmyKOL
Clinical trialNCT00589121CompletedPhase 2Interventional

Image-Guided Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Shoulder, Arm, Hip, or Leg

SponsorRadiation Therapy Oncology GroupEnrollment98LymphedemaMusculoskeletal ComplicationsRadiation FibrosisRadiation ToxicitySarcoma
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

RATIONALE: Image-guided radiation therapy uses high-energy x-rays to kill tumor cells. Specialized radiation therapy that delivers a lower dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. PURPOSE: This phase II trial is studying the side effects and how well image-guided radiation therapy works in treating patients with primary soft tissue sarcoma of the shoulder, arm, hip, or leg.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • Cross Cancer Institute at University of Alberta

    Edmonton, Alberta, Canada

  • London Regional Cancer Program at London Health Sciences Centre

    London, Ontario, Canada

  • Mcgill Cancer Centre at Mcgill University

    Montreal, Quebec, Canada

United States
  • Ccop - Christiana Care Health Services

    Newark, Delaware, United States

  • University of Florida Shands Cancer Center

    Gainesville, Florida, United States

  • Mayo Clinic - Jacksonville

    Jacksonville, Florida, United States

  • University of Miami Sylvester Comprehensive Cancer Center - Miami

    Miami, Florida, United States

  • H. Lee Moffitt Cancer Center and Research Institute at University of South Florida

    Tampa, Florida, United States

  • Norton Suburban Hospital

    Louisville, Kentucky, United States

  • Massachusetts General Hospital

    Boston, Massachusetts, United States

  • William Beaumont Hospital - Royal Oak Campus

    Royal Oak, Michigan, United States

  • Mayo Clinic Cancer Center

    Rochester, Minnesota, United States

  • Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center

    Lebanon, New Hampshire, United States

  • Roswell Park Cancer Institute

    Buffalo, New York, United States

  • Penn State Hershey Cancer Institute at Milton S. Hershey Medical Center

    Hershey, Pennsylvania, United States

  • Norris Cotton Cancer Center - North

    Saint Johnsbury, Vermont, United States

  • Medical College of Wisconsin Cancer Center

    Milwaukee, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Chemotherapy →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Mar 2008
Primary completion
31 Dec 2012
Completion
21 May 2018
Last update posted
12 Jun 2019
Registered enrollment
98
Registry id
NCT00589121
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.